Reported covered position: Legislative Assistant, Office of Sen. Richard Shelby; Health Research and Policy Assistant, Senate Committee on Health, Education, Labor and Pension
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Stop COVID–19 Test Surprise Medical Bills Act of 2021
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2022 · first_quarter · Q1
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
Source: Senate LDA
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
Further Extending Government Funding Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
COVID Supplemental Appropriations Act, 2022
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
COVID Supplemental Appropriations Act, 2022
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
Tracking COVID–19 Variants Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
VALID Act of 2021
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
Tracking COVID–19 Variants Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
Telehealth Extension and Evaluation Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
Telehealth Extension and Evaluation Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
PREVENT Pandemics Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
PREVENT Pandemics Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
Further Extending Government Funding Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Further Extending Government Funding Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Further Extending Government Funding Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Further Extending Government Funding Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
VALID Act of 2021
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
VALID Act of 2021
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
VALID Act of 2021
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
VALID Act of 2021
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: AMERICAN CLINICAL LABORATORY ASSN · Firm: AMERICAN CLINICAL LABORATORY ASSN
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93), H.R.791 - Tracking COVID-19 Variants Act, S.236 - Tracking COVID-19 Variants Act, H.R.533 - Stop COVID-19 Test Surprise Medical Bills Act of 2021, H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act, P.L. 117-103 FY2022 Consolidated Appropriations Act, H.R. 7007 COVID Supplemental Appropriations Act, 2022, S. 3593 Telehealth Extension and Evaluation Act, S. 3799 PREVENT Pandemics Act. .
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2021 · fourth_quarter · 4A
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN CLINICAL LABORATORY ASSN via AMERICAN CLINICAL LABORATORY ASSN
2021 · fourth_quarter · Q4
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office